Delivery Order SPE2DR25D3504-SPE2DR26F7BS5
- Not listed
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $10,626.56 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 15, 2025, with completion expected by December 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for Act-O-Vials on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026. The order will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.60 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,813.78 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award involved no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.42 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company will perform the work from its Corporate Office...
- The Defense Logistics Agency awarded a $5,671.37 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for Act-O-Vials pharmaceutical supplies, with an ultimate completion date of December 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $5,313.28 to AmerisourceBergen Drug Corp for Act-O-Vials on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for Act-O-Vials on July 29, 2025, with completion targeted for July 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger pharmaceutical supply contract with DLA. The award specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7BS5Delivery Order
The Defense Logistics Agency awarded a $2,656.66 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. This delivery order for Act-O-Vials—sterile vial delivery devices used in pharmaceutical applications—exemplifies the company's role in supporting the Defense Health Agency and broader Department of Defense medical supply chain operations. The award underscores AmerisourceBergen's established capability to fulfill federal medical procurement requirements through open competition, as evidenced by its extensive portfolio of delivery orders with DLA covering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/15/25 |